Literature DB >> 8003063

Racial differences in the distribution of systemic sclerosis-related serum antinuclear antibodies.

M Kuwana1, Y Okano, J Kaburaki, T Tojo, T A Medsger.   

Abstract

OBJECTIVE: To determine racial differences in the frequencies of systemic sclerosis (SSc)-related serum antinuclear antibodies (ANA).
METHODS: We tested serum samples from 275 Japanese, 416 North American Caucasian, and 24 North American black SSc patients for 8 SSc-related serum ANA, using indirect immunofluorescence, double immunodiffusion, and radioimmunoprecipitation assays.
RESULTS: In comparing the 3 racial groups, we found that anti-U1 RNP, anti-RNA polymerase I, II, and III, and anti-U3 RNP antibodies were the most frequently detected antibodies in Japanese, Caucasian, and black patients, respectively. Anti-PM-Scl antibody was found exclusively in Caucasians.
CONCLUSION: The production of SSc-related serum ANA is related to immunogenetic background.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8003063     DOI: 10.1002/art.1780370619

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  25 in total

Review 1.  Systemic sclerosis: a world wide global analysis.

Authors:  Paola Coral-Alvarado; Aryce L Pardo; Natalia Castaño-Rodriguez; Adriana Rojas-Villarraga; Juan-Manuel Anaya
Journal:  Clin Rheumatol       Date:  2009-03-11       Impact factor: 2.980

2.  Immunoglobulin allotype gene polymorphisms in systemic sclerosis: interactive effect of MHC class II and KM genes on anticentromere antibody production.

Authors:  H Kameda; J P Pandey; J Kaburaki; H Inoko; M Kuwana
Journal:  Ann Rheum Dis       Date:  1998-06       Impact factor: 19.103

Review 3.  How useful are serum autoantibodies in the diagnosis and prognosis of systemic sclerosis?

Authors:  O Meyer
Journal:  Clin Rheumatol       Date:  1998       Impact factor: 2.980

4.  Detection of anti-topoisomerase I autoantibody in patients with silicosis.

Authors:  Akiko Tomokuni; Takemi Otsuki; Haruko Sakaguchi; Yumika Isozaki; Fuminori Hyodoh; Masayasu Kusaka; Ayako Ueki
Journal:  Environ Health Prev Med       Date:  2002-04       Impact factor: 3.674

5.  Clinical setting of patients with systemic sclerosis by serum autoantibodies.

Authors:  U Picillo; S Migliaresi; M R Marcialis; A M Ferruzzi; G Tirri
Journal:  Clin Rheumatol       Date:  1997-06       Impact factor: 2.980

6.  Anti-fibrillarin antibody in African American patients with systemic sclerosis: immunogenetics, clinical features, and survival analysis.

Authors:  Roozbeh Sharif; Marvin J Fritzler; Maureen D Mayes; Emilio B Gonzalez; Terry A McNearney; Hilda Draeger; Murray Baron; Daniel E Furst; Dinesh K Khanna; Deborah J del Junco; Jerry A Molitor; Elena Schiopu; Kristine Phillips; James R Seibold; Richard M Silver; Robert W Simms; Marilyn Perry; Carlos Rojo; Julio Charles; Xiaodong Zhou; Sandeep K Agarwal; John D Reveille; Shervin Assassi; Frank C Arnett
Journal:  J Rheumatol       Date:  2011-05-15       Impact factor: 4.666

Review 7.  Clinical Trial Design Issues in Systemic Sclerosis: an Update.

Authors:  Jessica K Gordon; Robyn T Domsic
Journal:  Curr Rheumatol Rep       Date:  2016-06       Impact factor: 4.592

8.  T cell proliferative response induced by DNA topoisomerase I in patients with systemic sclerosis and healthy donors.

Authors:  M Kuwana; T A Medsger; T M Wright
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

9.  A case of renal crisis in a Korean scleroderma patient with anti-RNA polymerase I and III antibodies.

Authors:  Eun Ha Kang; Churl Hyun Im; Su Ho Kim; Jae Rak Chung; Eun Young Lee; Dong Jo Kim; Eun Bong Lee; Yeong Wook Song
Journal:  J Korean Med Sci       Date:  2006-12       Impact factor: 2.153

10.  The role of B cells in systemic sclerosis.

Authors:  Marina D Kraaij; Jacob M van Laar
Journal:  Biologics       Date:  2008-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.